HOME >> BIOLOGY >> NEWS
Common asthma drug saves patients money, trips to hospital

s. Patient data was used only if the patient hadn't taken any of the three drugs for the first nine months, followed by nine months of using one of the prescribed medications.

"Our findings are based on real-world data," Pathak said. "We analyzed the data after doctors had already prescribed one of the three drugs to their patients."

Patient data was split into three groups, based on the drug prescribed: 284 patients used fluticasone propionate in either 0.044 or 0.110 milligram doses; 302 used montelukast in 5 and 10 milligram doses; and 195 used zafirlukast in 20 milligram doses. The latter two drugs were taken in tablet form.

The average total cost of asthma care for a patient using fluticasone propionate during the nine-month period was $528. The cost was nearly double for montelukast users ($967), and it nearly tripled for zafirlukast users ($1,359). Total cost included filling prescriptions, trips to doctors' offices and emergency rooms, hospitalizations and the need for additional medication to control asthma symptoms.

The use of fluticasone propionate was also linked to fewer hospitalizations and less of a need for additional medication to control asthma symptoms - the data showed that patients could get by longer on a regimen of fluticasone propionate alone.

"An inhaled corticosteroid, which fluticasone propionate is, should be considered the first line of therapy in patients with symptoms of
'"/>

Contact: Dev Pathak
Pathak.1@osu.edu
614-688-3956
Ohio State University
10-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
Cached News: